Combination therapy comprising the administration of an 11.beta.-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist for treating some forms of cancer, diseases and disorders having inflammation as a component, and to minimize the side effects associated with glucorticoid receptor agonist therapy.

 
Web www.patentalert.com

< Methods of simultaneously treating ocular rosacea and acne rosacea

< Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier

> Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery

> Pyrazolopyrimidines as protein kinase inhibitors
~ 00259